What is the estimated glomerular filtration rate (EGFR) limit for administering contrast in a patient undergoing a contrasted MRI, particularly in those with impaired renal function or other risk factors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the considerations for using Contrast-Enhanced Computed Tomography (CECT) scans in patients with Impaired Renal Function?

In a patient with renal failure (eGFR <30 mL/min/1.73 m²), when is contrast‑enhanced CT indicated and what precautions should be taken?

What are the guidelines for using contrast dye in patients with impaired renal function, specifically those with a low estimated Glomerular Filtration Rate (eGFR)?

Is a CT (Computed Tomography) abdomen with or without contrast indicated for diagnosing pancreatic insufficiency?

Can contrast be used in patients with impaired renal function, specifically those with an estimated glomerular filtration rate (eGFR) of 47?

What are the symptoms and treatment options for a patient suspected of having strep throat?

What dietary approach is recommended for a patient with diverticulitis (inflammation of the diverticula in the digestive tract)?

What are the symptoms of Addison's disease?

Should a patient with impaired renal function (eGFR 30-60), indicating stage 3 Chronic Kidney Disease (CKD), be admitted earlier for hydration?

What is the expected effectiveness of the flu shot for the 2025-2026 influenza season, especially for high-risk individuals such as the elderly, young children, and people with chronic health conditions?

What is the evidence-based method to reduce the risk of nephrogenic systemic fibrosis (NSF) in patients with severe kidney disease, particularly those with end-stage renal disease (ESRD) or acute kidney injury (AKI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.